Livzon Pharmaceutical Group, Inc. Financials

Market Capitalization CN¥31.20 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	17.27
Forward PE	15.07
Price to Sales TTM	CN¥2.63
Price to Book MRQ	CN¥2.45
Enterprise to Revenue	2.42
Enterprise to EBITDA	8.71

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	17.08%
Operating Margin	28.77%
Return on Assets TTM	5.92%
Return on Equity TTM	15.09%

Income Statement

Revenue TTM	CN¥11,856,849,920
Revenue per Share TTM	CN¥12.83
Quarterly Revenue Growth	-5.60%
Gross Profit TTM	CN¥7,964,564,964
EBITDA	CN¥3,058,475,866
Net Income to Common TTM	CN¥2,024,829,952
Diluted EPS TTM	CN¥2.19
Quarterly Earnings Growth YoY	7.40%

Balance Sheet

Total Cash MRQ	CN¥10,809,157,632
Total Cash per Share MRQ	CN¥11.79
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	27.46
Current Ratio MRQ	1.84
Book Value per Share MRQ	CN¥15.44

Cash Flow

Operating Cash Flow TTM	CN¥3,344,446,208
Levered Free Cash Flow TTM	CN¥2,059,110,016

000513 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	620,768,000
Float Shares	484,063,333
Avg 10 Volume	8,544,072
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	42.00%
% Held by Institutions	17.19%

Stock Price Summary

Beta	0.28
Fifty Two Week Low	CN¥32.70
Fifty Two Week High	CN¥44.72
Fifty Two Week Change	2.46%
Day 50 MA	CN¥37.83
Day 200 MA	CN¥37.71

Dividends and Splits

Forward Annual Dividend Rate	CN¥5.40
Forward Annual Dividend Yield	14.94%
Trailing Annual Dividend Rate	CN¥1.35
Trailing Annual Dividend Yield	3.74%
Payout Ratio	61.64%
Dividend Date
Ex Dividend Date	2024-07-08
Last Split Factor
Last Split Date	2019-07-03